Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Standalone]

Mar2025Mar2024Mar2023
   PCE(x) 129.46--

What is the latest Price to Cash Earnings (PCE) ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of ONESOURCE SPECIALTY PHARMA is 129.46 based on Mar2025 Standalone results.
Year Price to Cash Earnings (PCE)
Mar2025129.46
Mar2024-
Mar2023-

How is Price to Cash Earnings (PCE) of ONESOURCE SPECIALTY PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 129.46
0
Mar2024 0
0
Mar2023 0 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹19,155.4 Cr 8.6% -8.5% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,343.0 Cr -0.7% 7.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹171,774.0 Cr -0.1% -4.8% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,665.0 Cr 2.2% 6.3% 11.4% Stock Analytics
CIPLA ₹122,878.0 Cr -0.6% 1.2% NA Stock Analytics
DR REDDYS LABORATORIES ₹106,581.0 Cr 1.5% 6.4% 4.8% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

8.6%

-8.5%

NA
SENSEX

-0.5%

1.5%

6.9%


You may also like the below Video Courses